Viral gene evolution is a dynamic process characterized by the continuous adaptation and modification of viral genetic material over time. This phenomenon is driven by several factors, including natural selection, genetic mutations, and recombination events, resulting in the diversity of viral populations. Mutations in viral genes occur as a natural consequence of viral replication, with some mutations conferring advantages, disadvantages, or neutral effects on viral fitness. Positive selection favors mutations that enhance viral replication, transmission, or evasion of host immune responses. Recombination, where genetic material from different viruses combines, further contributes to viral gene evolution. This process can lead to the emergence of novel viral strains with unique genetic compositions and potentially altered biological properties. Selective pressures, such as host immune responses and antiviral interventions, play a crucial role in shaping viral gene evolution. Rapid evolution allows viruses to evade immune recognition and develop resistance to antiviral drugs. Understanding viral gene evolution is essential for designing effective vaccines and antiviral strategies. Ongoing research explores the molecular mechanisms driving viral evolution, aiding in the prediction of emerging viral threats and the development of targeted interventions to mitigate their impact.
Title : A universal AI design framework and brokerage platform for democratised manufacturing of mRNA therapeutics
Duccio Medini, BioForge, United States
Title : Personalized and Precision Medicine (PPM) via biodesign-driven translational applications and upgraded business modeling to secure the human biosafety: The next-step vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Development of VSV-vector based vaccine against H5N1 avian influenza by targeting both H5N1 hemagglutinin and matrix protein 2
Zhujun Ao, University of Manitoba, Canada
Title : A novel responsive microneedle platform for reliable drug and vaccine delivery
Huanhuan Li, Queen’s University Belfast, United Kingdom
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : The promise of nanotechnology in Personalized & Precision Medicine: Nano-driven precision vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Comparative efficacy of different H9N2 avian influenza virus inactivated vaccines using some commercially available adjuvants for superior control in broilers
Ayman H M El Deeb, Cairo University, Egypt
Title : Structure-based design and development of next-generation Respiratory Syncytial Virus (RSV) vaccine
Lei Chen, Yikang Biotech Suzhou Co., Ltd, China
Title : Unmasking urban immunization inequities: A cross-sectional LQAS analysis of zero-dose drivers in slum and non-slum settings of Uttar Pradesh, India
Ashish Kumar Maurya, John Snow India, India